Multicompartment, Numerical Model of Cellular Events in the Pharmacokinetics of Gene Therapies

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Human Gene Therapy

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.1994.5.6-679PMID 7948130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic Considerations in the Use of Genes as Pharmaceuticals

  1994cited by this paper
• Are contemporary methods for somatic gene therapy suitable for clinical applications?

  1993cited by this paper
• Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in Mice

  1993cited by this paper
• Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.

  1992cited by this paper
• Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.

  1992cited by this paper
• A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes.

  1992cited by this paper
• Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.

  1992cited by this paper
• Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats.

  1991cited by this paper
• Adenovirus enhancement of transferrin-polylysine-mediated gene delivery.

  1991cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper
• Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo.

  1989cited by this paper
• Receptor-mediated gene delivery and expression in vivo.

  1988cited by this paper
• Use of computers in biology and medicine

  1965cited by this paper

• Model-based dose selection for gene therapy for haemophilia B

  2025cites this paper
• Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product.

  2023cites this paper
• Mathematical modelling of gene delivery in patients with haemophilia B

  2023cites this paper
• Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities

  2022cites this paper
• Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models.

  2021cites this paper
• Foreign Gene Expression in the Mouse Cauda Epididymis is Regulated by Androgens

  2018cites this paper
• Optimal model‐based control of non‐viral siRNA delivery

  2018cites this paper
• Modelling and Optimal Control of Non-Viral siRNA Delivery

  2016cites this paper
• Gene Therapy for Rheumatoid Arthritis.

  2016cites this paper
• Subcellular drug targeting, pharmacokinetics and bioavailability

  2014cites this paper
• Integrating mitosis, toxicity, and transgene expression in a telecommunications packet‐switched network model of lipoplex‐mediated gene delivery

  2014cites this paper
• Systemic and biophase bioavailability and pharmacokinetics of nanoparticulate drug delivery systems.

  2013cites this paper
• Influence of lipid components on gene delivery by polycation liposomes: Transfection efficiency, intracellular kinetics and in vivo tumor inhibition.

  2012cites this paper
• An efficient parallel stochastic simulation method for analysis of nonviral gene delivery systems

  2011cites this paper
• Gene Therapy: A Pharmacokinetic/Pharmacodynamic Modelling Overview

  2010influential citation
• A novel nonviral gene delivery system: multifunctional envelope-type nano device.

  2010cites this paper
• Gene transfer to the mammalian reproductive tract†

  2010cites this paper
• In-vivo gene transfer induces transgene expression in cells and secretions of the mouse cauda epididymis.

  2009cites this paper
• Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET.

  2008cites this paper
• Frequency and site mapping of HIV-1/SIVcpz, HIV- 2/SIVsmm and other SIV gene sequence cleavage by various bacteria restriction enzymes: Precursors for a novel HIV inhibitory product

  2007cites this paper
• Intracellular Kinetics of Non-Viral Gene Delivery Using Polyethylenimine Carriers

  2007cites this paper
• Quantitative analysis of non-viral gene therapy in primary liver culture systems

  2007cites this paper
• Model-based inference of gene expression dynamics from sequence information.

  2005cites this paper
• Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.

  2005cites this paper
• Pharmacokinetics of Gene Delivery in Cells

  2005cites this paper
• In vitro transfection of the human vas deferens using DNA-liposome and DNA-neutral lipid complexes.

  2004cites this paper
• Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways.

  2004cites this paper
• Rational design and engineering of delivery systems for therapeutics: biomedical exercises in colloid and surface science.

  2003cites this paper
• A model for the analysis of nonviral gene therapy

  2003cites this paper
• Gene, Oligonucleotide, and Ribozyme Therapy in the Eye

  2003cites this paper
• Biotechnology Products and Their Development

  2002cites this paper
• In vivo transfection of the mouse vas deferens.

  2002cites this paper
• Aliphatic ionenes as gene delivery agents: elucidation of structure-function relationship through modification of charge density and polymer length.

  2002cites this paper
• Lebergentherapie: Aktueller Stand und Ausblick

  2001cites this paper
• Quantitative analysis of synthetic gene delivery vector design properties.

  2001cites this paper
• Safety and Pharmacokinetics of Naked Plasmid DNA: Studies on Dissemination and Ectopic Expression

  2001cites this paper
• Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA.

  2001cites this paper
• Clinical trials of a new class of therapeutic agents: antisense oligonucleotides

  2001cites this paper
• Safety and pharmacokinetics of naked plasmid DNA in the skin: studies on dissemination and ectopic expression.

  2001cites this paper
• In-vivo transfection of the female reproductive tract epithelium.

  2000cites this paper
• Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design

  2000cites this paper
• Delivery of Recombinant Gene Products to the Central Nervous System with Nonautologous Cells in Alginate Microcapsules

  1999cites this paper
• Lipoplex-mediated gene transfer : Influence of selected chemotherapeutic agents on transgene expression

  1999cites this paper
• The pharmacology of gene therapy.

  1999cites this paper
• Biodistribution of radiolabeled lipid-DNA complexes and DNA in mice.

  1998cites this paper
• Pharmacokinetic considerations in somatic gene therapy.

  1998cites this paper
• From genes to gene medicines: recent advances in nonviral gene delivery.

  1998cites this paper
• Polylysine-based transfection systems utilizing receptor-mediated delivery.

  1998cites this paper
• Ligand substitution of receptor targeted DNA complexes affects gene transfer into hepatoma cells

  1998cites this paper
• Clinical Aspects of Gene Therapy

  1998cites this paper
• Pharmacokinetics of Local Vector Delivery to Vascular Tissues: Implications for Efficiency and Localization of Transduction

  1997cites this paper
• Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations.

  1997cites this paper
• DNA Vaccines

  1997cites this paper
• GENETIC THERAPY: Past, Present, and Future

  1997cites this paper
• Peptide-mediated gene delivery: influence of peptide structure on gene expression.

  1997cites this paper
• Development of targeted delivery systems for nucleic acid drugs.

  1997cites this paper
• Cationic Lipid-Based Gene Delivery Systems: Pharmaceutical Perspectives

  1997cites this paper
• Approaches to enhance cancer radiotherapy employing gene transfer methods.

  1996cites this paper
• Controllable gene therapy pharmaceutics of non-viral gene delivery systems

  1996cites this paper
• Gene therapy in pediatric medicine.

  1996cites this paper
• Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.

  1996cites this paper
• Controllable Gene Therapy: Recent Advances in Non-Viral Gene Delivery

  1996cites this paper
• Quantitative analysis of transient gene expression in mammalian cells using the green fluorescent protein.

  1996cites this paper
• Uptake and intracellular trafficking of asialoglycoprotein-polylysine-DNA complexes in isolated rat hepatocytes.

  1996cites this paper
• Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice

  1995cites this paper
• Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products

  1995cites this paper
• Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.

  1995cites this paper
• Gene Transfer to Synovial Cells by Intra-Articular Administration of Plasmid DNA

  1995cites this paper
• Non-viral gene therapy.

  1994cites this paper
• In Vivo Gene Transfer into Rabbit Thyroid Follicular Cells by Direct DNA Injection

  1994cites this paper
• Overexpression of Human Methylmalonyl CoA Mutase in Mice after In Vivo Gene Transfer with Asialoglycoprotein/Polylysine/DNA Complexes

  1994cites this paper
• Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in Mice

  1993cites this paper